Eton Pharmaceuticals (ETON) FCF Margin (2019 - 2025)
Eton Pharmaceuticals (ETON) posted FCF Margin of 54.51% for Q4 2025, down 204.26% sequentially from 52.28% in Q3 2025, and down 4784.0% YoY from 1.16% in Q4 2024.
Eton Pharmaceuticals (ETON) FCF Margin (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals has reported FCF Margin for 7 years, with the latest figure at 54.51% in Q4 2025.
- Quarterly FCF Margin fell 4784.0% year-over-year to 54.51% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 12.75% (up 1033.0% YoY) and the FY2025 annual result came in at 12.75%, up 1033.0% from the prior year.
- FCF Margin declined to 54.51% in Q4 2025 per ETON's latest filing, from 52.28% in the prior quarter.
- Over five years, FCF Margin peaked at 59.21% in Q2 2023 and troughed at 380.9% in Q3 2021.
- A 5-year average of 12.09% and a median of 12.26% in 2023 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 1425297 bps in 2021, down 24095071 bps in 2021.
- Over 5 years, FCF Margin stood at 84.05% in 2021, then surged by 140 bps to 33.28% in 2022, then slumped by 96 bps to 1.3% in 2023, then sank by 614 bps to 6.67% in 2024, then slumped by 717 bps to 54.51% in 2025.
- According to Business Quant data, FCF Margin over the past three periods registered 54.51%, 52.28%, and 42.05% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.87 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 32.47 Bn | 30.79 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.38 Bn | 19.71 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.90 Bn | 11.37 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.71 Bn | 1.69 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -54.51% |
| Sep 30, 2025 | 52.28% |
| Jun 30, 2025 | 42.05% |
| Mar 31, 2025 | 12.09% |
| Dec 31, 2024 | -6.67% |
| Sep 30, 2024 | 28.59% |
| Jun 30, 2024 | 13.83% |
| Mar 31, 2024 | -31.22% |
| Dec 31, 2023 | 1.30% |
| Sep 30, 2023 | 12.42% |
| Jun 30, 2023 | 59.21% |
| Mar 31, 2023 | -29.19% |
| Dec 31, 2022 | 33.28% |
| Sep 30, 2022 | -34.06% |
| Jun 30, 2022 | 49.00% |
| Mar 31, 2022 | 55.51% |
| Dec 31, 2021 | -84.05% |
| Sep 30, 2021 | -380.90% |
| Jun 30, 2021 | -12.03% |
| Mar 31, 2021 | 31.23% |